Chinese medicine composition for treating cardiac cancer

Abstract

The invention relates to a Chinese medicine composition for treating cardiac cancer, which is prepared from the following raw materials in parts by weight: 2-4 parts of herba polygoni avicularis, 0.8-1.5 parts of plantain herb, 0.8-1.2 parts of moxa stick, 0.8-1.2 parts of common fennel, 1.5-2.5 parts of cogongrass rhizome and 0.8-1.2 parts of rhizoma polygonati. After all raw materials are mixedaccording to the weight part and grinded into powders which can be directly orally taken. The invention has the advantages of remarkable curative effect, low cost, simple treating manner, conveniencefor medicine administration and almost non-toxic and side effects; in addition, the effective rate of the traditional Chinese medicine composition is more than 92% through the clinical observation.

Description

[0001] technical field [0002] The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine composition for treating cardia cancer. Background technique [0003] Cardiac carcinoma is an adenocarcinoma that occurs in the gastric cardia, that is, within about 2 cm below the esophagogastric junction. It is a special type of gastric cancer and should be distinguished from lower esophageal cancer. However, it is different from other gastric cancers in that it has its own anatomical and histological characteristics and clinical manifestations, unique diagnosis and treatment methods, and poor surgical treatment effect. In my country, the mortality and morbidity of cardiac cancer ranks among the top among all kinds of malignant tumors. According to data, the mortality rate of cardia cancer accounts for about 12% of the total mortality rate, and it can reach 20% in local high-incidence areas. In recent y...

AI Technical Summary

Problems solved by technology

It is precisely because most of the surgeries are emergency surgeries, and the preparations in all aspects are not sufficient, the incidence of surgical complications and mortality of these patients are high, and the curative effect is poor.

[0004] For a long time, surgical treatment has been recognized as the first choice for cardia cancer, but the cost of surgical treatment is high, the damage to the human body is great, and the postoperative recurrence rate is high, and survival low rate

Also, because of histology of adenocarcinoma or mucinous adenocarcinoma, radiation therapy is rarely effective and chemotherapy is minimally effective